Péter Nyírády

Semmelweis University — Hungary

Medicine · Health Sciences

30h-index3.4kcitations324works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(79), Urinary and Genital Oncology Studies(60), Urological Disorders and Treatments(56), Prostate Cancer Treatment and Research(53), Prostate Cancer Diagnosis and Treatment(41)

Publications323 total

Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer
Prostate Cancer and Prostatic Diseases·2025Open Access
Evaluating oncoplastic breast-conserving surgery: oncological safety, risks, and satisfaction—a systematic review and meta-analysis
Scientific Reports·2025Open Access
Risk factors for vaginal wall erosion after pelvic organ prolapse surgery with implant: a systematic review and meta-analysis
Scientific Reports·2025Open Access
Discordant findings in genome-wide noninvasive prenatal testing for rare chromosomal abnormalities, adverse pregnancy outcomes, and maternal malignancies: a systematic review and meta-analysis
American Journal of Obstetrics and Gynecology·2025Open Access
Clinical and Molecular Predictors of Response and Survival in Patients with Urothelial Carcinoma Treated with Enfortumab Vedotin: A Systematic Review and Meta-analysis
European Urology Open Science·2025Open Access
Impact of lifestyle and environmental factors on fertility
Current Opinion in Urology·2025· 2 citedOpen Access
Lymphovascular Invasion is Predictive for Adjuvant Platinum Therapy Benefit in Urothelial Bladder Cancer
Clinical Genitourinary Cancer·2025Open Access
Oncological Efficacy and Safety of Minimally Invasive Focal and Whole-Gland Interventions in the Treatment of Low- and Intermediate-Risk Prostate Cancer: A Systematic Review and Meta-Analysis
Cancers·2025· 2 citedOpen Access
Demographic, socioeconomic and functional health-related factors in the selection of vaginal pessaries used for the conservative treatment of pelvic organ prolapse: a retrospective study
BMC Women s Health·2025· 2 citedOpen Access
Prostate radiotherapy in patients with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis of randomised controlled trials
Clinical and Translational Radiation Oncology·2025Open Access
Radical Surgery Compared to Bladder-Preserving Approaches for Limited Stage Small-Cell Bladder Cancer: Systematic Review and Meta-Analysis
Clinical Genitourinary Cancer·2025Open Access
Real‐World Overall Survival Comparison of Enzalutamide and Abiraterone In First‐ and Second‐Line Setting of Metastatic Castration‐Resistant Prostate Cancer
The Prostate·2025Open Access
Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life—A Systematic Review and Meta-analysis
European Urology Focus·2025· 7 citedOpen Access
Toxicities of PARP inhibitors in genitourinary cancers
Current Opinion in Urology·2025· 2 citedOpen Access
Neoadjuvant strategies in locally advanced prostate cancer: progress or premature?
Translational Andrology and Urology·2025Open Access
IP12-03 CLINICAL VALUE OF PREOPERATIVE PLASMA HER2 AND EPIDERMAL GROWTH FACTOR RECEPTOR IN PATIENTS WITH CLINICALLY LOCALIZED UTUC: A RETROSPECTIVE MULTICENTER COHORT STUDY
The Journal of Urology·2025
Assessing the efficacy of varicocelectomy, antioxidants, FSH treatment, and lifestyle modifications on sperm DNA fragmentation: a systematic review and meta-analysis
Scientific Reports·2025· 6 citedOpen Access
Optimal Aspirin Dosage for the Prevention of Preeclampsia and Other Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Journal of Clinical Medicine·2025· 2 citedOpen Access
Prognostic and predictive value of pre-treatment blood-based inflammatory biomarkers in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Frontiers in Immunology·2025· 2 citedOpen Access
Efficacy and Safety of Combination Therapy with PARP Inhibitors and Anti-Angiogenic Agents in Ovarian Cancer: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine·2025· 5 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Tibor Szarvas(18), Henning Reis(13), Attila Szendrői(11), Shahrokh F. Shariat(10), Orsolya Módos(9), Boris Hadaschik(9), Christian Niedworok(8), Nándor Ács(7), Stephan Tschirdewahn(7), Imre Romics(7), András Kiss(6), Péter Hegyi(6), H. Rübben(6), Attila Marcell Szász(6), Alex Váradi(5), Ulrich Krafft(4), Tamás Fazekas(4), Anita Csizmarik(4), Ilona Kovalszky(4), József Tı́már(4)